Ho Won Kang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Kidney Stones and Urolithiasis Treatments
- Ferroptosis and cancer prognosis
- Renal cell carcinoma treatment
Papers in
-
- Kidney Stones and Urolithiasis Treatments 14
- Prostate Cancer Treatment and Research 12
- Prostate Cancer Diagnosis and Treatment 12
- Ferroptosis and cancer prognosis 8
- Renal cell carcinoma treatment 8
- Surgery 41
- Bladder and Urothelial Cancer Treatments 38
- Urinary and Genital Oncology Studies 18
- Co-authors
- Wun‐Jae Kim (89 shared papers)Seok Joong Yun (91 shared papers)Won Tae Kim (68 shared papers)Sang‐Cheol Lee (59 shared papers)Yong‐June Kim (59 shared papers)Yun-Sok Ha (32 shared papers)Yung Hyun Choi (30 shared papers)Pildu Jeong (26 shared papers)
- Journals
- Journal of Korean Medical Science (13 papers)International Journal of Molecular Sciences (5 papers)The Journal of Urology (5 papers)Urologic Oncology Seminars and Original Investigations (4 papers)Oncotarget (4 papers)
- Partner nations
- South KoreaUnited StatesPuerto Rico
In The Last Decade
Ho Won Kang
121 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 106
- Cancer Research 325
- Pulmonary and Respiratory Medicine 541
- Surgery 399
- Oncology 226
- Molecular Biology 595
Countries citing papers authored by Ho Won Kang
This map shows the geographic impact of Ho Won Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Won Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Won Kang more than expected).
Fields of papers citing papers by Ho Won Kang
This network shows the impact of papers produced by Ho Won Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Won Kang. The network helps show where Ho Won Kang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ho Won Kang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 125 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 90 | |
| 2 | 2020 | 57 | |
| 3 | 2013 | 52 | |
| 4 | 2012 | 51 | |
| 5 | 2015 | 45 | |
| 6 | 2018 | 44 | |
| 7 | 2016 | 42 | |
| 8 | 2008 | 40 | |
| 9 | 2016 | 38 | |
| 10 | 2016 | 34 | |
| 11 | 2017 | 34 | |
| 12 | 2018 | 34 | |
| 13 | 2021 | 32 | |
| 14 | 2019 | 31 | |
| 15 | 2014 | 30 | |
| 16 | 2014 | 29 | |
| 17 | 2014 | 28 | |
| 18 | 2014 | 27 | |
| 19 | 2018 | 26 | |
| 20 | 2020 | 26 |
About Ho Won Kang
Ho Won Kang is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Cancer Research, Molecular Biology and Oncology, having authored 125 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (38 papers), Urinary and Genital Oncology Studies (18 papers), Kidney Stones and Urolithiasis Treatments (14 papers), Epigenetics and DNA Methylation (14 papers), Prostate Cancer Treatment and Research (12 papers), Prostate Cancer Diagnosis and Treatment (12 papers), Ferroptosis and cancer prognosis (8 papers) and Renal cell carcinoma treatment (8 papers). The work is most often cited by research in Cancer Research (325 citations), Pulmonary and Respiratory Medicine (541 citations), Surgery (399 citations), Oncology (226 citations) and Molecular Biology (595 citations). Ho Won Kang has collaborated with scholars based in South Korea, United States and Puerto Rico. Frequent co-authors include Wun‐Jae Kim, Seok Joong Yun, Won Tae Kim, Sang‐Cheol Lee, Yong‐June Kim, Yun-Sok Ha, Yung Hyun Choi, Pildu Jeong, Sung Pil Seo and Tae Gyun Kwon. Their work appears in journals such as Journal of Korean Medical Science, International Journal of Molecular Sciences, The Journal of Urology, Urologic Oncology Seminars and Original Investigations and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.